Biomea fusion to participate in citi's smid biotech c-suite fireside chat series

San carlos, calif., oct. 21, 2025 (globe newswire) -- biomea fusion, inc. (“biomea”) (nasdaq: bmea), a clinical-stage diabetes and obesity company, today announced that it will participate in citi's smid biotech c-suite fireside chat series on thursday, october 23, 2025, at 8:00 a.m. pacific time / 11:00 a.m. eastern time.

SMID Ratings Summary

SMID Quant Ranking